IPSEN (OTCMKTS:IPSEY) Shares Gap Up – What’s Next?

IPSEN (OTCMKTS:IPSEY) gapped up prior to trading on Wednesday . The stock had previously closed at $34.93, but opened at $36.3596. IPSEN shares last traded at $36.3596, with a volume of 136 shares changing hands.

Wall Street Analyst Weigh In

IPSEY has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of IPSEN in a research report on Monday, November 3rd. BNP Paribas lowered shares of IPSEN to an “underperform” rating in a research note on Wednesday, November 26th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

IPSEN Stock Performance

The company’s 50-day moving average is $35.90 and its 200-day moving average is $33.61.

IPSEN Company Profile

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).